A recent study has shown what seemed obvious, out of country stem cell outfits injecting adult stem cells via an intravenous route fail to get those cells to the target organs being treated. Regrettably, these cells don’t end up in the brain, liver, heart, joints, pancreas, etc… they end up in the lungs. This is similar to the hepatic first pass effect seen in drug delivery (in that case it’s the liver). At this point in time, credible stem cell delivery is direct to the organ or tissue being treated. So if you want cells in the liver or brain, you have to place them there. If you want cells in the joint or in a tendon tear, again you have to place them directly in that area. Organizations doing this type of credible adult stem cell delivery include
Regenerative Sciences and
Regenocyte.
There are also outfits in Asia who understand this type of delivery.
Tags: adult stem cells, cells, intravenous, IV, mesenchymal stem cells, msc, pulmonary, pulmonary first pass, stem, stem cell, stem cells
Note: Patient testimonials highlighted on the Regenexx website are not indicative of all patient results.
This entry was posted
on Thursday, January 8th, 2009 at 1:27 pm and is filed under Latest News.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.